Physician profile
Heather Tate
NPI 1174032247
$2,309.88
in general payments reported to CMS, 2019-2025
25 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $335 · 2022: $565 · 2023: $437 · 2024: $521 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $376.00 | 2021-2025 | |
| Pfizer INC. | $363.35 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $222.31 | 2021-2024 | Xarelto |
| Amgen INC. | $195.42 | 2022-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.43 | 2022-2025 | Jardiance |
| Esperion Therapeutics, INC. | $163.42 | 2022-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $114.84 | 2022-2023 | Verquvo |
| Boston Scientific Corporation | $81.87 | 2021-2023 | Bodyguardian |
| Novo Nordisk INC | $81.24 | 2022-2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $80.23 | 2021-2023 | |
| Alnylam Pharmaceuticals INC. | $67.93 | 2024-2025 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $53.24 | 2021-2025 | Wainua, Farxiga |
| Kestra Medical Technology Services, INC. | $47.35 | 2023-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $46.43 | 2021-2025 | Camzyos |
| Regeneron Healthcare Solutions, INC. | $35.30 | 2024-2025 | Evkeeza |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $35.13 | 2025 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $26.17 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.51 | 2021 | |
| Amarin Pharma, INC. | $22.14 | 2021 | |
| Scpharmaceuticals INC. | $20.45 | 2024 | |
| Angiodynamics, INC. | $19.23 | 2022 | |
| Philips North America LLC | $18.57 | 2023 | |
| Abbott Laboratories | $17.82 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $15.17 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $13.33 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Tate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.